摘要
目的探讨布地奈德复合异丙托溴胺雾化对气管插管全身麻醉手术患者的影响。方法选取2015年1月~2018年1月我院气管插管全身麻醉60例手术患者的临床资料,依据治疗方式不同分为对照组和雾化组,每组各30例。雾化组给予布地奈德复合异丙托溴胺雾化治疗,对照组给予非雾化治疗。观察两组气管插管后25、40 min气道峰值压情况,观察两组麻醉前、麻醉苏醒后的血氧饱和度(SpO_2)、氧分压(PO_2)、二氧化碳分压(PCO_2)情况。结果雾化组气管插管后25、40 min气道峰值压低于对照组,差异有统计学意义(P<0.05)。两组麻醉前SpO_2、PO_2、PCO_2比较,差异无统计学意义(P>0.05),麻醉苏醒后两组的SpO_2、PO_2均高于麻醉前,PCO_2低于麻醉前,雾化组麻醉苏醒后SpO_2、PO_2均高于对照组,PCO_2低于对照组,差异有统计学意义(P<0.05)。结论布地奈德复合异丙托溴胺雾化在气管插管全身麻醉手术应用可以降低气道峰值压,提高PO_2,值得临床推广应用。
Objective To investigate the effect of Budesonide combined with Ipratropium Bromide on patients undergoing general anesthesia for endotracheal intubation. Methods The clinical data of 60 patients with general anesthesia for tracheal intubation from January 2015 to January 2018 in our hospital were analyzed. The patients were divided into control group and atomization group according to different treatment methods, 30 cases in each group. The atomization group was given Budesonide combined with Ipratropium Bromide anebulization therapy, the control group was given non-aerosol treatment. The peak airway pressure was observed 25 and 40 min after tracheal intubation in the two groups. The blood oxygen saturation(SpO_2), oxygen partial pressure(PO_2) and carbon dioxide partial pressure(PCO_2) of the two groups before anesthesia and awakening after anesthesia were observed. Results The peak airway pressure was lower in the atomization group than that in the control group 25 and 40 min after tracheal intubation(P<0.05). There were no significant differences in SpO_2, PO_2 and PCO_2 between the two groups before anesthesia(P>0.05). Awakening after anesthesia, SpO_2 and PO_2 in the two groups were higher than those before anesthesia, while PCO_2 was lower than before anesthesia. In the atomization group, the SpO_2 and PO_2 levels were higher than those in the control group after anesthesia, while the PCO_2 was lower than that of the control group(P<0.05). Conclusion The application of Budesonide combined with Ipratropium Bromide atomization on patients undergoing general anesthesia for tracheal intubation can reduce the peak pressure of airway and increase the partial pressure of blood oxygen, which is worthy of clinical promotion.
引文
[1]宋琳苑.雾化吸入布地奈德与异丙托溴胺治疗老年性慢性阻塞性肺病的效果分析[J].中国当代医药,2017,24(29):18-20.
[2]Gao Y,Cheng Y,Dong S,et al.Effect of perioperative treatment with ambroxol on lung cancer patients after video-assisted thoracic surgery lobectomy[J].J Cent Sou Univer(Med Sci),2014,39(8):849-54.
[3]陈良华.孟鲁司特与布地奈德和复方异丙托溴胺雾化吸入联用对小儿呼吸道感染后咳嗽的疗效评价[J].抗感染药学,2015,12(5):770-772.
[4]Nakajima T,Yasufuku K,Sakairi Y,et al.Successful treatment of lung cancer by multimodal endobronchial interventions[J].Respiration,2014,88(2):144-147.
[5]龚艺.布地奈德联合异丙托溴胺雾化吸入对老年肺叶切除患者肺功能及炎性因子的影响[J].中国老年学杂志,2015,35(17):4929-4930.
[6]Melo F,Nunes JP,Vasconcelos M,et al.Stress-induced cardiomyopathy associated with ipratropium bromide therapy in a patient with chronic obstructive pulmonary disease[J].Rev Port Cardiol,2014,33(3):e1-e4.
[7]林磊,姜格宁.布地奈德联合异丙托溴胺雾化吸入对老年肺癌肺叶切除患者肺功能保护的研究[J].海南医学院学报,2014,20(10):1377-1379.
[8]Poullis M.The effect of postoperative change in bronchial angle on postoperative pulmonary function after upper lobectomy in lung cancer patients[J].Interact Cardiovasc Thorac Surg,2014,18(2):188.
[9]张庆礼,孙大勇,凌涛,等.布地奈德、特布他林、异丙托溴胺雾化联合甲强龙治疗支气管哮喘急性重症发作时的疗效观察[J].中国医药科学,2018,8(3):79-82.
[10]ItogaNK,Kinoshita CK,Masutani SM,et al.Mechanical factors affect-ing nebulized albuterol aerosol particle sizes for asthma drug delivery[J].Am J Emerg Med,2014,32(6):569-572.
[11]李秀华,廖根松.特布他林与布地奈德雾化吸入对支气管哮喘患儿的疗效及其对血清TNF-α、IL-6水平及肺功能的影响[J].抗感染药学,2017,14(2):372-374.
[12]Levy ML,Hardwell A,Mc Knight E,et al.Asthmapatients inability to use a pressurised metered-dose inhaler(p MDI)correctly correlates with poor asthma control as defined by the global initiative for asthma(GINA)strategy:a retrospective analysis[J].Prim Care Respir J,2013,22(4):406-411.
[13]沈晓伟.布地奈德联合复方异丙托溴胺雾化吸入预防全麻术后患者呼吸道并发症的临床疗效[J].天津药学,2017,29(3):40-41,78.
[14]Ewing P,Ryrfeldt A,Sj(o)berg CO.Vasoconstriction after inhalation of budesonide:a study in the isolated and perfused rat lung[J].Pulm Pharmacol Ther,2010,23(1):9-14.
[15]房春花,梁丽华,罗育琴,等.布地奈德、特布他林及异丙托溴胺三联雾化吸入治疗COPD患者的疗效及护理[J].中国医药科学,2017,7(9):84-87.
[16]Price D,Keininger D,Costa-Scharplatz M,et al.Cost effectiveness of the LABA/LAMA dual bronchodilator indacaterol/gly-copyrronium in a Swedish healthcare setting[J].Respir Med,2014,108(12):1786-1793.
[17]陈燕青,王家东,徐雅男,等.布地奈德雾化吸入对全身麻醉气管插管术后咽喉部并发症的缓解作用[J].上海交通大学学报(医学版),2011,31(12):1746-1749.
[18]Sun YX,Gong CH,Liu S,et al.Effect of inhaled MgSO4on FEV1and PEF in children with asthma induced by acetylcholine:a random-ized controlled clinical trail of 330 cases[J].Trop Pediatr,2014,60(2):141-147.